Cargando…

Rapid targeted gene disruption in Bacillus anthracis

BACKGROUND: Anthrax is a zoonotic disease recognized to affect herbivores since Biblical times and has the widest range of susceptible host species of any known pathogen. The ease with which the bacterium can be weaponized and its recent deliberate use as an agent of terror, have highlighted the imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Saldanha, Roland J, Pemberton, Adin, Shiflett, Patrick, Perutka, Jiri, Whitt, Jacob T, Ellington, Andrew, Lambowitz, Alan M, Kramer, Ryan, Taylor, Deborah, Lamkin, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848504/
https://www.ncbi.nlm.nih.gov/pubmed/24047152
http://dx.doi.org/10.1186/1472-6750-13-72
_version_ 1782293767250771968
author Saldanha, Roland J
Pemberton, Adin
Shiflett, Patrick
Perutka, Jiri
Whitt, Jacob T
Ellington, Andrew
Lambowitz, Alan M
Kramer, Ryan
Taylor, Deborah
Lamkin, Thomas J
author_facet Saldanha, Roland J
Pemberton, Adin
Shiflett, Patrick
Perutka, Jiri
Whitt, Jacob T
Ellington, Andrew
Lambowitz, Alan M
Kramer, Ryan
Taylor, Deborah
Lamkin, Thomas J
author_sort Saldanha, Roland J
collection PubMed
description BACKGROUND: Anthrax is a zoonotic disease recognized to affect herbivores since Biblical times and has the widest range of susceptible host species of any known pathogen. The ease with which the bacterium can be weaponized and its recent deliberate use as an agent of terror, have highlighted the importance of gaining a deeper understanding and effective countermeasures for this important pathogen. High quality sequence data has opened the possibility of systematic dissection of how genes distributed on both the bacterial chromosome and associated plasmids have made it such a successful pathogen. However, low transformation efficiency and relatively few genetic tools for chromosomal manipulation have hampered full interrogation of its genome. RESULTS: Group II introns have been developed into an efficient tool for site-specific gene inactivation in several organisms. We have adapted group II intron targeting technology for application in Bacillus anthracis and generated vectors that permit gene inactivation through group II intron insertion. The vectors developed permit screening for the desired insertion through PCR or direct selection of intron insertions using a selection scheme that activates a kanamycin resistance marker upon successful intron insertion. CONCLUSIONS: The design and vector construction described here provides a useful tool for high throughput experimental interrogation of the Bacillus anthracis genome and will benefit efforts to develop improved vaccines and therapeutics.
format Online
Article
Text
id pubmed-3848504
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38485042013-12-04 Rapid targeted gene disruption in Bacillus anthracis Saldanha, Roland J Pemberton, Adin Shiflett, Patrick Perutka, Jiri Whitt, Jacob T Ellington, Andrew Lambowitz, Alan M Kramer, Ryan Taylor, Deborah Lamkin, Thomas J BMC Biotechnol Methodology Article BACKGROUND: Anthrax is a zoonotic disease recognized to affect herbivores since Biblical times and has the widest range of susceptible host species of any known pathogen. The ease with which the bacterium can be weaponized and its recent deliberate use as an agent of terror, have highlighted the importance of gaining a deeper understanding and effective countermeasures for this important pathogen. High quality sequence data has opened the possibility of systematic dissection of how genes distributed on both the bacterial chromosome and associated plasmids have made it such a successful pathogen. However, low transformation efficiency and relatively few genetic tools for chromosomal manipulation have hampered full interrogation of its genome. RESULTS: Group II introns have been developed into an efficient tool for site-specific gene inactivation in several organisms. We have adapted group II intron targeting technology for application in Bacillus anthracis and generated vectors that permit gene inactivation through group II intron insertion. The vectors developed permit screening for the desired insertion through PCR or direct selection of intron insertions using a selection scheme that activates a kanamycin resistance marker upon successful intron insertion. CONCLUSIONS: The design and vector construction described here provides a useful tool for high throughput experimental interrogation of the Bacillus anthracis genome and will benefit efforts to develop improved vaccines and therapeutics. BioMed Central 2013-09-18 /pmc/articles/PMC3848504/ /pubmed/24047152 http://dx.doi.org/10.1186/1472-6750-13-72 Text en Copyright © 2013 Saldanha et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Saldanha, Roland J
Pemberton, Adin
Shiflett, Patrick
Perutka, Jiri
Whitt, Jacob T
Ellington, Andrew
Lambowitz, Alan M
Kramer, Ryan
Taylor, Deborah
Lamkin, Thomas J
Rapid targeted gene disruption in Bacillus anthracis
title Rapid targeted gene disruption in Bacillus anthracis
title_full Rapid targeted gene disruption in Bacillus anthracis
title_fullStr Rapid targeted gene disruption in Bacillus anthracis
title_full_unstemmed Rapid targeted gene disruption in Bacillus anthracis
title_short Rapid targeted gene disruption in Bacillus anthracis
title_sort rapid targeted gene disruption in bacillus anthracis
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848504/
https://www.ncbi.nlm.nih.gov/pubmed/24047152
http://dx.doi.org/10.1186/1472-6750-13-72
work_keys_str_mv AT saldanharolandj rapidtargetedgenedisruptioninbacillusanthracis
AT pembertonadin rapidtargetedgenedisruptioninbacillusanthracis
AT shiflettpatrick rapidtargetedgenedisruptioninbacillusanthracis
AT perutkajiri rapidtargetedgenedisruptioninbacillusanthracis
AT whittjacobt rapidtargetedgenedisruptioninbacillusanthracis
AT ellingtonandrew rapidtargetedgenedisruptioninbacillusanthracis
AT lambowitzalanm rapidtargetedgenedisruptioninbacillusanthracis
AT kramerryan rapidtargetedgenedisruptioninbacillusanthracis
AT taylordeborah rapidtargetedgenedisruptioninbacillusanthracis
AT lamkinthomasj rapidtargetedgenedisruptioninbacillusanthracis